Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Matrigel Market Soars with a CAGR of 11.5% | Insights on Phenol Red and Phenol Red-Free Applications - Valuates Reports

This image opens in the lightbox

News provided by

Valuates Reports

23 Jan, 2025, 15:21 GMT

Share this article

Share toX

Share this article

Share toX

BANGALORE, India, Jan. 23, 2025 /PRNewswire/ -- Matrigel Market is Segmented by Type (Contains Phenol Red, Phenol Red Free), by Application (Biotechnology and Pharmaceutical Companies, Research and Academic Institutes).

The Global Matrigel Market is projected to grow from USD 85 Million in 2024 to USD 163.3 Million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period.

Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-4W13526/Global_Matrigel_Market

Major Factors Driving the Growth of Matrigel Market:

The Matrigel market is experiencing robust growth, driven by its critical role in advanced research and development across biotechnology, pharmaceutical, and academic sectors. Matrigel's ability to mimic the extracellular matrix makes it indispensable for 3D cell culture, cancer modeling, and stem cell research.

The market benefits from collaborations between research organizations and private companies, accelerating innovations in personalized medicine and biotherapeutics. As the demand for precision and predictive preclinical models grows, Matrigel continues to expand its applications in regenerative medicine, oncology, and drug discovery.

View Full Report Now! https://reports.valuates.com/market-reports/QYRE-Auto-4W13526/global-matrigel

TRENDS INFLUENCING THE GROWTH OF THE MATRIGEL MARKET:

The inclusion of phenol red in Matrigel formulations has significantly contributed to the growth of the Matrigel market by enhancing its utility in cell culture applications. Phenol red acts as a pH indicator, providing researchers with a visual cue of the culture medium's pH levels, ensuring an optimal environment for cell growth and differentiation.

This feature is particularly valuable in regenerative medicine, stem cell research, and drug discovery, where consistent results are critical. Additionally, phenol red-containing Matrigel is widely used in 3D cell culture systems for studying cancer, organoids, and tissue engineering due to its ability to mimic in vivo environments effectively. The demand for reliable and reproducible research tools in biotechnology and pharmaceutical industries has further boosted the adoption of phenol red-enhanced Matrigel.

The increasing demand for phenol red-free Matrigel is a significant growth driver in the Matrigel market, particularly in applications requiring minimal interference with cellular signaling pathways. Phenol red-free formulations are preferred in sensitive experiments, including hormone research, stem cell differentiation, and cancer studies, where the presence of phenol red may alter experimental outcomes. This type of Matrigel ensures accurate and reproducible results, making it an essential tool for precision research. The rising adoption of phenol red-free Matrigel in pharmaceutical and biotechnology sectors reflects the growing emphasis on high-quality, interference-free reagents for drug discovery and therapeutic development. Additionally, its widespread use in in vitro fertilization (IVF) procedures highlights its importance in clinical and diagnostic applications.

Matrigel provides an extracellular matrix (ECM)-like environment that supports cell attachment, proliferation, and differentiation, making it indispensable for drug discovery, toxicology studies, and tissue engineering. Pharmaceutical companies utilize Matrigel to evaluate drug efficacy and safety in 3D cell culture systems, enabling more accurate predictions of in vivo responses. In the biotechnology sector, Matrigel is widely used for stem cell research, organoid development, and cancer modeling, driving innovations in regenerative medicine and oncology. The increasing focus on personalized medicine and biotherapeutics has further heightened the demand for high-quality Matrigel formulations. Collaborations between research organizations and industry players, along with rising investments in life sciences, continue to expand the applications of Matrigel, contributing significantly to market growth.

The growing adoption of 3D cell culture models is a key factor driving the Matrigel market. Unlike traditional 2D cultures, 3D systems mimic the in vivo cellular environment, offering more accurate and physiologically relevant results. Matrigel, with its ECM-like composition, provides an ideal scaffold for 3D cultures, enabling the study of complex cellular behaviors such as migration, invasion, and differentiation.

This capability has made Matrigel indispensable for cancer research, drug discovery, and tissue engineering. Additionally, regulatory agencies emphasize the need for more predictive preclinical models, further fueling the demand for 3D culture systems. Pharmaceutical and biotechnology companies are increasingly incorporating Matrigel into their workflows to improve the success rate of drug development pipelines.

Stem cell research represents a significant growth area for the Matrigel market. Matrigel provides a supportive microenvironment for the proliferation and differentiation of stem cells, making it essential for regenerative medicine and therapeutic applications. Researchers use Matrigel to culture pluripotent and mesenchymal stem cells, ensuring their stability and functionality for downstream applications. Its role in organoid development has further expanded its utility in studying organ-specific diseases and developing personalized treatment options.

Additionally, the ability of Matrigel to support 3D stem cell cultures has enhanced its importance in tissue engineering and cellular therapy research. As global research into stem cell-based therapies intensifies, the demand for reliable and high-quality Matrigel formulations continues to grow, contributing significantly to market expansion.

The expanding scope of cancer research has significantly boosted the demand for Matrigel, particularly in studying tumor biology and developing anti-cancer therapies. Matrigel provides an ECM-like environment that supports the growth of tumor spheroids and organoids, enabling researchers to model the tumor microenvironment in vitro. This capability is critical for understanding tumor progression, metastasis, and resistance mechanisms, driving the development of targeted therapies. Pharmaceutical companies use Matrigel-based models to evaluate the efficacy of novel cancer drugs, reducing the reliance on animal studies and improving translational outcomes. Additionally, Matrigel is widely used in invasion and migration assays to study the behavior of cancer cells under different conditions. The increasing prevalence of cancer worldwide and the push for personalized oncology solutions continue to drive investments in cancer research. Consequently, the role of Matrigel in advancing cancer studies remains integral to its market growth.

Claim Yours Now! https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-4W13526&lic=single-user

MATRIGEL MARKET SHARE

The Matrigel market exhibits strong growth across regions, with North America leading due to its advanced research infrastructure, significant investments in biotechnology, and a strong pharmaceutical sector.  US & Canada is the largest market, with a share of about 38%, which is driven by extensive funding for cancer and stem cell research.

In terms of application, Biotechnology and Pharmaceutical Companies has a share about 73 percent.

In terms of product type, Contains Phenol Red is the largest segment, occupied for a share of about 68%.

Global key players of Matrigel include Corning and Thermo Fisher Scientific, etc. The top two players hold a share over 73%.

Key Companies:

  • Corning Inc
  • Yeasen Biotechnology
  • Solarbio Science & Technology
  • R&D Systems
  • MEGAROBO
  • ACROBiosystems
  • Beyotime
  • Live Biotechnology
  • Mogengel Biotechnology
  • Thermo Fisher Scientific

Purchase Chapters: https://reports.valuates.com/market-reports/QYRE-Auto-4W13526/global-matrigel/1

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

DISCOVER MORE INSIGHTS: EXPLORE SIMILAR REPORTS!

  • Matrigel Basement Membrane Matrix Market
  • Matrigel Gel Cell Culture Medium market was valued at USD 415 Million in 2023 and is anticipated to reach USD 703 Million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
  • Low Endotoxin Matrigel market was valued at USD 560 Million in 2023 and is anticipated to reach USD 730 Million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
  • LDEV-free Matrigel Market
  • Phenol Red-Free Matrigel Market
  • Basement Membrane Matrigel Market
  • Cell Culture Media Market
  • Cell Culture Media Sera and Reagents Market
  • Cell Culture Monitoring System Market was estimated to be worth USD 60 Million in 2023 and is forecast to a readjusted size of USD 95 Million by 2030 with a CAGR of 5.6% during the forecast period 2024-2030.
  • Serum for Cell Culture Market
  • Cell Culture Vessels market is projected to grow from USD 526.6 Million in 2024 to USD 755.5 Million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.

DISCOVER OUR VISION: VISIT ABOUT US!

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

GET A FREE QUOTE

Valuates Reports

sales@valuates.com

For U.S. Toll-Free Call 1-(315)-215-3225

WhatsApp: +91-9945648335

Website: https://reports.valuates.com

Blog: https://valuatestrends.blogspot.com/

Pinterest: https://in.pinterest.com/valuatesreports/

Twitter: https://twitter.com/valuatesreports

Facebook: https://www.facebook.com/valuatesreports/

YouTube: https://www.youtube.com/@valuatesreports6753

https://www.facebook.com/valuateskorean 

https://www.facebook.com/valuatesspanish 

https://www.facebook.com/valuatesjapanese 

https://valuatesreportspanish.blogspot.com/ 

https://valuateskorean.blogspot.com/ 

https://valuatesgerman.blogspot.com/ 

https://valuatesreportjapanese.blogspot.com/ 

Logo - https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg

Modal title

Also from this source

Burn-In Test System for Semiconductor Market to Hit USD 1.4 Billion by 2031, Driven by IC and Sensor Demand

Burn-In Test System for Semiconductor Market to Hit USD 1.4 Billion by 2031, Driven by IC and Sensor Demand

Burn-In Test System for Semiconductor Market is Segmented by Type (Static Testing, Dynamic Testing), by Application (Integrated Circuit, Sensor,...

Server Liquid Cold Plate Market Surges with 62.3% CAGR | Key Growth in Internet & Telecom Sectors

Server Liquid Cold Plate Market Surges with 62.3% CAGR | Key Growth in Internet & Telecom Sectors

Server Liquid Cold Plate Market is Segmented by Type (Copper Type, Copper+Aluminum Type), by Application (Internet, BFSI, Telecom, Energy,...

More Releases From This Source

Explore

Biotechnology

Biotechnology

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.